The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Prospective Study of Pathogen Burden and Risk of Myocardial Infarction or Death
Open accessAbstract
Background —We previously demonstrated that the risk of coronary artery disease (CAD) increased in relation to the number of pathogens (the “pathogen burden”) in a cross-sectional study. In the present prospective study with a different patient cohort, we evaluated the effect of pathogen burden on the risk of myocardial infarction (MI) or death among CAD patients. Methods and Results —IgG antibodies to cytomegalovirus (CMV), hepatitis A virus (HAV), herpes simplex virus type 1 (HSV1), HSV type 2 (HSV2), Chlamydia pneumoniae and Helicobacter pylori , and C-reactive protein (CRP) levels were tested in baseline blood samples from 890 patients who had significant CAD on angiography. The mean follow-up period was 3 years. The baseline prevalence of antibodies directed against CMV, HAV, HSV1, or HSV2, but not C pneumoniae and H pylori, was significantly higher among patients who subsequently developed MI or death than among control subjects. After adjustment for traditional risk factors, number of diseased vessels, and clinical presentation, relative hazards (95% confidence limits) for MI or death were 2.0 (1.4 to 3.2) for CMV, 1.6 (1.1 to 2.3) for HAV, and 1.5 (1.0 to 2.2) for HSV2. Increasing pathogen burden was significantly associated with increasing risk of MI or death in a dose-response fashion. Adjusted relative hazards of MI or death associated with pathogen burden were significant among individuals with low or high CRP levels. Conclusions —The results suggest that infection plays an important role in incident MI or death and that the risk posed by infection is independently related to the pathogen burden.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men
Ridker, P. M., Cushman, M., Stampfer, M. J., Tracy, R. P., & Hennekens, C. H. (1997) · New England Journal of Medicine · doi:10.1056/nejm199704033361401 · Cited by 5,504
The Prognostic Value of C-Reactive Protein and Serum Amyloid A Protein in Severe Unstable Angina
Liuzzo, G., Biasucci, L. M., Gallimore, J. R., Grillo, R. L., Rebuzzi, A. G., Pepys, M. B., & Maseri, A. (1994) · New England Journal of Medicine · doi:10.1056/nejm199408183310701 · Cited by 2,357
Saikku, P., Mattila, K., Nieminen, M. S., Huttunen, J. K., Leinonen, M., Ekman, M.-R., Mäkelä, P. H., & Valtonen, V (1988) · The Lancet · doi:10.1016/s0140-6736(88)90741-6 · Cited by 1,964
Emerging Epidemic of Cardiovascular Disease in Developing Countries
Reddy, K. S., & Yusuf, S. (1998) · Circulation · doi:10.1161/01.cir.97.6.596 · Cited by 1,206
Saikku, P., Leinonen, M., Tenkanen, L., Linnanmäki, E., Ekman, M.-R., Manninen, V., Mänttäri, M., Frick, M. H., & Huttunen, J. K. (1992) · Annals of Internal Medicine · doi:10.7326/0003-4819-116-4-273 · Cited by 786
Potential Role of Human Cytomegalovirus and p53 Interaction in Coronary Restenosis
Speir, E., Modali, R., Huang, E.-S., Leon, M. B., Shawl, F., Finkel, T., & Epstein, S. E. (1994) · Science · doi:10.1126/science.8023160 · Cited by 753
Self-citationRelation of Helicobacter pylori infection and coronary heart disease.
Mendall, M. A., Goggin, P. M., Molineaux, N., Levy, J., Toosy, T., Strachan, D., Camm, A. J., & Northfield, T. C. (1994) · Heart · doi:10.1136/hrt.71.5.437 · Cited by 658
Infection and Atherosclerosis: Emerging Mechanistic Paradigms
Epstein, S. E., Zhou, Y. F., & Zhu, J. (1999) · Circulation · doi:10.1161/01.cir.100.4.e20 · Cited by 511
Self-citationZhou, Y. F., Leon, M. B., Waclawiw, M. A., Popma, J. J., Yu, Z. X., Finkel, T., & Epstein, S. E. (1996) · New England Journal of Medicine · doi:10.1056/nejm199608293350903 · Cited by 451
Self-citationMuhlestein, J. B., Hammond, E. H., Carlquist, J. F., Radicke, E., Thomson, M. J., Karagounis, L. A., Woods, M. L., & Anderson, J. L. (1996) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(96)00055-1 · Cited by 420
Self-citation
Cited by
Interleukin-18 Is a Strong Predictor of Cardiovascular Death in Stable and Unstable Angina
Blankenberg, S., Tiret, L., Bickel, C., Peetz, D., Cambien, F., Meyer, J., & Rupprecht, H. J. (2002) · Circulation · doi:10.1161/01.cir.0000020546.30940.92 · Cited by 568
Inflammation as a Driver of Adverse Left Ventricular Remodeling After Acute Myocardial Infarction
Westman, P. C., Lipinski, M. J., Luger, D., Waksman, R., Bonow, R. O., Wu, E., & Epstein, S. E. (2016) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2016.01.073 · Cited by 506
Self-citationThe interaction of bacterial pathogens with platelets
Fitzgerald, J. R., Foster, T. J., & Cox, D. (2006) · Nature Reviews Microbiology · doi:10.1038/nrmicro1425 · Cited by 489
Autoimmune and Inflammatory Mechanisms in Atherosclerosis
Wick, G., Knoflach, M., & Xu, Q. (2004) · Annual Review of Immunology · doi:10.1146/annurev.immunol.22.012703.104644 · Cited by 431
Smith, T. W., & Ruiz, J. M. (2002) · Journal of Consulting and Clinical Psychology · doi:10.1037//0022-006x.70.3.548 · Cited by 361
SÖDERBERG‐NAUCLÉR, C. (2006) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2006.01618.x · Cited by 349
Manifestations of Human Cytomegalovirus Infection: Proposed Mechanisms of Acute and Chronic Disease
Britt, W. (2008) · Current Topics in Microbiology and Immunology · doi:10.1007/978-3-540-77349-8_23 · Cited by 345
Septicemia, access and cardiovascular disease in dialysis patients: The USRDS Wave 2 Study
Ishani, A., Collins, A. J., Herzog, C. A., & Foley, R. N. (2005) · Kidney International · doi:10.1111/j.1523-1755.2005.00414.x · Cited by 313
Predisposition to Atherosclerosis by Infections: Role of Endothelial Dysfunction
Prasad, A., Zhu, J., Halcox, J. P. J., Waclawiw, M. A., Epstein, S. E., & Quyyumi, A. A. (2002) · Circulation · doi:10.1161/01.cir.0000021125.83697.21 · Cited by 308
Self-citation<EMPH TYPE="ITAL">Chlamydia pneumoniae</EMPH> as an Emerging Risk Factor in Cardiovascular Disease
Kalayoglu, M. V. (2002) · JAMA · doi:10.1001/jama.288.21.2724 · Cited by 283
Rupprecht, H. J., Blankenberg, S., Bickel, C., Rippin, G., Hafner, G., Prellwitz, W., Schlumberger, W., & Meyer, J. (2001) · Circulation · doi:10.1161/hc2601.091703 · Cited by 253
Andraws, R., Berger, J. S., & Brown, D. L. (2005) · JAMA · doi:10.1001/jama.293.21.2641 · Cited by 235
Slopen, N., Koenen, K. C., & Kubzansky, L. D. (2012) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2011.11.003 · Cited by 151
Burden of infection and insulin resistance in healthy middle-aged men
Fernández-Real, J.-M., López-Bermejo, A., Vendrell, J., Ferri, M.-J., Recasens, M., & Ricart, W. (2006) · Diabetes Care · doi:10.2337/dc05-2068 · Cited by 106
An Association of Herpes Simplex Virus Type 1 Infection With Type 2 Diabetes
Sun, Y., Pei, W., Wu, Y., & Yang, Y. (2005) · Diabetes Care · doi:10.2337/diacare.28.2.435 · Cited by 46
“The presence of antibodies to HSV-1 is reported to be associated with an increase in the risk of incident myocardial infarction and coronary heart death (5,6).”
BackgroundHaeseker, M. B., Pijpers, E., Dukers-Muijrers, N. H., Nelemans, P., Hoebe, C. J., Bruggeman, C. A., Verbon, A., & Goossens, V. J. (2013) · Immunity & Ageing · doi:10.1186/1742-4933-10-30 · Cited by 46
Grąbczewska, Z., Nartowicz, E., Kubica, J., & Rość, D. (2006) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2006.02.005 · Cited by 20
“influenzae, cytomegalovirus (CMV), Epstein–Barr virus (EBV), herpes simplex virus type 1 and 2 (HSV-1 and 2), and hepatitis A virus (HAV) [8,9].”
BackgroundInfluential
Metadata
- Authors
- Zhu, J., Nieto, F. J., Horne, B. D., Anderson, J. L., Muhlestein, J. B., & Epstein, S. E.
- Venue
- Circulation
- Published
- 2001-01-02
- Volume
- 103
- Issue
- 1
- Pages
- 45-51
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W2101249520
- Cited by
- 279
- References
- 24
- FWCI
- 21.15
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.